@syngenis

Syngenis Pty Ltd - Your Custom Oligonucleotide Synthesis Specialist based in Australia.

 Bentley Technology Park
syngenis.com
Joined March 2021
  • Tweets18
  • Following39
  • Followers47
Antibody-like specificity, without the antibody. Aptamers are structured DNA or RNA that bind their target with antibody-like specificity, for therapeutics and point of care diagnostics. We do not just make them. We design them. syngenis.com #Aptamers
DNA render with the headline Antibody-like, without the antibody. Designed by Discovery AI. Made in our laboratory.

ALT DNA render with the headline Antibody-like, without the antibody. Designed by Discovery AI. Made in our laboratory.

3
8 - 26 Weeks That is how long offshore oligo supply can take, from order to material in hand. Almost none of it is chemistry. It is freight, customs and a queue you cannot see. Ours are made here, by chemists in your time zone. syngenis.com
Large figure 8 to 26 weeks, offshore lead time from order to material in hand, over a synthesiser with amber reagent bottles.

ALT Large figure 8 to 26 weeks, offshore lead time from order to material in hand, over a synthesiser with amber reagent bottles.

10
Preliminary data wins grants. The absence of it loses them. Our $2,500 Preliminary Data Award goes against design and synthesis for an antisense, siRNA, aptamer or CRISPR project. Open to investigators at Australian universities and MRIs. Closes 30 November.
Large figure $2,500, Preliminary Data Award, applied against design and synthesis. Submissions close 30 November 2026.

ALT Large figure $2,500, Preliminary Data Award, applied against design and synthesis. Submissions close 30 November 2026.

11
Your sequence does not need a passport. We make custom DNA and RNA oligonucleotides in our own laboratory in Western Australia. Your sequence, your material and your intellectual property stay in the country. syngenis.com
Navy graded map of Australia with the headline Your DNA stays in Australia. Custom DNA and RNA oligonucleotides, made in Western Australia.

ALT Navy graded map of Australia with the headline Your DNA stays in Australia. Custom DNA and RNA oligonucleotides, made in Western Australia.

1
16
Meet Silvana Carnachan, our Head of Quality and Regulatory Affairs at Syngenis. To find out how Silvana’s role assists in producing and providing high quality oligonucleotides, visit syngenis.com/silvana-carnach…
Meet Emma Carr, Our Operations Officer at Syngenis. Emma loves to challenge her strength through rock climbing and enjoy exploring marine life through her scuba diving adventures. To find out more about Emma's background, visit syngenis.com/emma-carr/
#HarmonyDay celebrations at #Syngenis. #DiversityandInclusion Read more: linkedin.com/feed/update/urn…
3
4
Thank you If Innovation Could Talk for giving us an opportunity to discuss about SynGenis. It has been a wonderful experience sharing our passion, expertise and capabilities in oligonucleotide manufacturing. linkedin.com/posts/syngenis_…
Syngenis, @epichem, Gene S and @XytoVet received a small business grant from the Town of Victoria Park to showcase #Biotechnology #TechPark. So mark your calendars for the 18th March 2022 from 10AM to 2PM to experience the best what Tech Park has to offer! syngenis.com/syngenis-showca…
1
Introducing our #CompanyBoard - Meet George Bautovich, our founding director. Currently #Nuclear #Medicine #physician in the Department of Nuclear Medicine at Royal North Shore Hospital syngenis.com/george-bautovic…
1
Proud to receive an @MTPConnect_AUS #Manufacturing voucher to establish #ISO and #GMP certification for our products! Thanks to the WA Life Sciences Innovation Hub! syngenis.com/manufacturing-b…
1
6
Join us at #ISNAC2021 organised by #JSNAC next week to hear the latest on #oligonucleotide and #nucleicacid research! isnac2021.jp/
Exciting new results on #antisenseoligonucleotides and #siRNA research by the @Rakesh N. Veedu and Hiroshi Abe teams. Congratulations! chemistry-europe.onlinelibra…
2
Introducing our #CompanyBoard - Meet Steve Arnott, our Chairman A wealth of #BusinessExpertise and currently the CEO of @PerronInstitute syngenis.com/steve-arnott/
4
From Cancer to COVID‐19: A Perspective on Targeting Heparan Sulfate‐Protein Interactions onlinelibrary.wiley.com/doi/… An account of our work on heparan sulfate mimetics over the years. Thanks to @NehaGan53599560, @MohitCh25978605, @_nwsee and Gareth Doherty.
3
16
Introducing our #Board - Meet Martin Blake, our Founding Director Serial #entrepreneur and currently chairman of @PerthRadClinic and @ResonanceHealth syngenis.com/martin-blake/
1
2
Introducing our #Board - Meet #MarvinCaruthers, our Founding Director For many known as the father of #Oligonucleotide #synthesis and co-founder of @Amgen, Applied Biosystems, @ArrayBioPharma and miRagen Therapeutics syngenis.com/marvin-caruther…
2
Introducing our #Board - Meet @RakeshVeedu, our Founder and Managing Director A @PerronInstitute #McCusker fellow and the head of the #NucleicAcid #Therapeutics Research based at the Centre for Molecular Medicine and Innovative Therapeutics @MurdochUni lnkd.in/gxXayJRD

LinkedIn

This link will take you to a page that’s not on LinkedIn

lnkd.in
4
Load more